Dudediligence.

10x Genomics, Inc

TXGNASDAQ · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$151.7MSep ’24$165.0MDec ’24$154.9MMar ’25$172.9MJun ’25$149.0MSep ’25$166.0MDec ’25$150.8MMar ’26$151.0MJun ’26
Net income, by quarter
−$35.8MSep ’24−$49.0MDec ’24−$34.4MMar ’25$34.5MJun ’25−$27.5MSep ’25−$16.2MDec ’25−$13.5MMar ’26−$17.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$490.5M$516.4M$618.7M$610.8M$642.8M
Gross profit$416.4M$396.0M$409.3M$414.5M$443.9M
Operating income−$52.3M−$167.9M−$265.3M−$194.6M−$61.0M
Net income−$58.2M−$166.0M−$255.1M−$182.6M−$43.5M
Operating cash flow−$21.4M−$33.6M−$15.2M$6.7M$136.1M
Free cash flow−$122.7M−$165.3M−$63.8M−$5.7M$130.1M
Cash$596.1M$227.4M$359.3M$344.1M$474.0M
Shares outstanding112.5M115.2M119.1M122.3M127.7M